Bruker Introduces Routine Gradient Spectroscopy and Robust, Industry-Standard PAL® Automation on High-Performance Fourier™ 80 Benchtop FT-NMR System

ZUERICH–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) announces the European launch of the high-performance Fourier™ 80 system, a next-generation, 80 MHz Fourier Transform Nuclear Magnetic Resonance (FT-NMR) benchtop spectrometer, now with major new capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201019005105/en/ The new Fourier 80 brings the power of NMR to the... Read more

Thermo Fisher Scientific Launches Modular Closed Cell Processing System for Cell Therapy Manufacturing

Thermo Fisher Scientific Launches Modular Closed Cell Processing System for Cell Therapy Manufacturing CARLSBAD, Calif., Oct. 15, 2020 /PRNewswire/ — Thermo Fisher Scientific announced the launch of its Gibco CTS Rotea Counterflow Centrifugation System, a modular, closed cell therapy processing system that enables scalable, cost-effective cell therapy development and manufacturing. The CTS Rotea system is the... Read more

GE Healthcare Receives FDA Clearance for Vivid Ultra Edition, AI-Powered Cardiovascular Ultrasound System Designed to Shorten Diagnostic Exam Time and Improve Measurement Consistency

Chicago (October 12, 2020) – GE Healthcare today announced U.S. FDA 510k clearance for its Ultra Edition package on Vivid[1] cardiovascular ultrasound systems, which includes new features based on artificial intelligence (AI) that enable clinicians to acquire faster, more repeatable exams consistently. Methodical assessments of heart function are key in echocardiography but can be tedious... Read more

Pacific Biosciences Launches the Sequel IIe System to Accelerate Adoption of Highly Accurate HiFi Sequencing

MENLO PARK, Calif., Oct. 05, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced the launch of the Sequel® IIe System, the next instrument evolution based on the company’s Single Molecule, Real-Time (SMRT®) Sequencing technology. With increased computational capacity and on-instrument data... Read more

BD Granted FDA 510(k) Clearance for BD FACSLyric™ Flow Cytometer with Newly Integrated BD FACSDuet™ Sample Preparation System

FRANKLIN LAKES, N.J., Oct. 5, 2020 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the BD FACSLyric™ Flow Cytometer with the Integrated BD FACSDuet™ Sample Preparation System. The new integrated system enables clinical laboratories to fully automate... Read more

Roche’s phase III EMPACTA study showed Actemra/RoActemra reduced the likelihood of needing mechanical ventilation in hospitalised patients with COVID-19 associated pneumonia

EMPACTA is the first global phase III trial to show efficacy with Actemra/RoActemra in COVID-19 associated pneumonia and the first with a focus on enrolling largely underserved and minority patients There was no statistical difference in mortality between patients who received Actemra/RoActemra or placebo Roche plans to share these results with health authorities, including the... Read more

QIAGEN fully acquires NeuMoDx Molecular, Inc., rounding out portfolio of PCR-based diagnostic automation systems

Hilden, Germany and Ann Arbor, Michigan, September 17, 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the acquisition of the remaining 80.1% of diagnostics instruments company NeuMoDx Molecular, Inc. for $248 million in cash. The move rounds out QIAGEN’s portfolio of automated molecular testing solutions based on the proven PCR technology.... Read more

Genomic Leaders Collaborate to Create Australia’s First National COVID-19 Tracking System

MELBOURNE, Australia–(BUSINESS WIRE)–Illumina (NASDAQ: ILMN) announced today that the Australian public health laboratories will aim to sequence the virus genomes of all positive COVID-19 tests in Australia and track COVID-19 using genomics across the country, rather than state by state, under a ground-breaking initiative spearheaded by Australia’s public health laboratory organisations and leading industry partners.... Read more

Thermo Fisher Scientific to Present at the Morgan Stanley Global Healthcare Conference on September 15, 2020

Thermo Fisher Scientific to Present at the Morgan Stanley Global Healthcare Conference on September 15, 2020 WALTHAM, Mass., Sept. 14, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the Morgan Stanley Global Healthcare Conference on... Read more

FBI Approves Thermo Fisher Scientific's Rapid DNA Solution for National DNA Index System

FBI Approves Thermo Fisher Scientific’s Rapid DNA Solution for National DNA Index System Applied Biosystems RapidHIT ID System plays key role in arrestee testing and investigative lead generation SOUTH SAN FRANCISCO, Calif., Sept. 8, 2020 /PRNewswire/ — The U.S. Federal Bureau of Investigation (FBI) has approved Thermo Fisher Scientific’s Applied Biosystems RapidHIT ID System for use... Read more